Complete your online assessment
Tell us about your health, your medications and what you want to change, all from home in Delaware. The questionnaire is short, there is nothing to schedule, and it works the same for everyone in Delaware.
Provider guided GLP-1 care
Personalized Compounded Semaglutide in Delaware.
An online path to personalized compounded semaglutide for people in Delaware. You answer a health questionnaire, a licensed provider reviews it, and if treatment is appropriate your prescription is filled by a pharmacy partner and delivered to you.
✓ LegitScript certified✓ Licensed providers✓ One price, every dose
How it works
Getting started in Delaware
Three steps, all online, from the first question to the delivery at your door.
A licensed provider reviews it
Your assessment goes to a licensed provider through Wasef Health, PC. Nothing is prescribed automatically: the provider evaluates your answers and makes the call on personalized compounded semaglutide.
Your prescription ships to you
A prescription, if one is issued, is dispensed by VialsRx, Bodi Envi's pharmacy partner for GLP-1 prescriptions, and delivered to your Delaware address.
Please note: a licensed provider determines whether treatment is appropriate. Treatment is not guaranteed. If a patient is not qualified, a refund will be issued.
Personalized Compounded Semaglutide: what it is and how it is used
The active ingredient, semaglutide, is a GLP-1 receptor agonist: a medication that engages the receptor for a hormone the digestive system produces around meals, one that influences appetite and blood sugar. It is the medication at the center of Bodi Envi's Personalized Compounded Semaglutide Weight-Management Programs for Delaware residents.
Personalized Compounded Semaglutide is a version of that active ingredient prepared by a licensed compounding pharmacy from a prescription written for an individual patient. It is taken as a weekly injection, and the starting dose and any later change are decided by the prescribing provider, not by the patient and not by Bodi Envi.
Compounded medications sit outside FDA approval. Personalized Compounded Semaglutide is not FDA-approved, is not equivalent to Ozempic® and Wegovy®, and is not reviewed by the FDA for safety, effectiveness or quality before it is marketed. That is why each prescription rests on a licensed provider's individual judgement. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Pricing
Personalized Compounded Semaglutide pricing for Delaware residents
There is one price list, and it applies in Delaware exactly as it does everywhere else. Pick the term that suits you, from monthly to twelve months, knowing that a dose adjustment from your provider will not raise the price.
Monthly
$155/ month
Billed monthly
3 months
$145/ month
$435 paid once
6 months
$135/ month
$810 paid once
12 months
$125/ month
$1,500 paid once
For applicable programs, pricing does not increase based solely on dosage strength. Medication is included only when a licensed healthcare provider determines treatment is medically appropriate and issues a prescription. Current pricing and plan details are on the Plans page.
What is included
- Online health assessment and review by a licensed provider
- Personalized Compounded Semaglutide when a provider determines it is appropriate
- Ongoing care team messaging and treatment monitoring
- Dispensing and delivery by a licensed pharmacy partner
- One price regardless of dose strength
Available across Delaware
Because nothing depends on a physical location, Delaware is served as a whole. Residents of Wilmington, Dover, Newark, Middletown, Smyrna and Milford and of the towns between them complete the same online assessment and, if personalized compounded semaglutide is prescribed, receive it at a valid address anywhere in the state.
How pharmacies serving Delaware are regulated
The Delaware Board of Pharmacy is the Delaware agency responsible for licensing and inspecting pharmacies that serve patients in the state. When personalized compounded semaglutide is prescribed, a licensed compounding pharmacy prepares it for that patient specifically. Bodi Envi is not a pharmacy, not a medical practice and not a manufacturer, and it does not compound medications. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards. Delaware Board of Pharmacy.
Read more
Why online care works in Delaware
Bodi Envi is a telehealth platform, so the whole process happens where you already are. Someone in Smyrna and someone in Milford complete the same assessment from home, are reviewed by the same licensed providers, and message the care team through the same secure channel. If personalized compounded semaglutide is prescribed, it is delivered to a home address in Delaware rather than collected from a clinic. Distance from a city stop being a factor in whether Delaware residents can be seen.
Questions
Personalized Compounded Semaglutide in Delaware
Straight answers about eligibility, pricing and how the program works where you live.
It is. Adults in Delaware can complete the online assessment, and a licensed provider decides whether personalized compounded semaglutide is appropriate for them. A prescription, if issued, is filled by the pharmacy partner and delivered to your Delaware address. Keep in mind that compounded medications are not FDA-approved.
The same four plans apply in Delaware as everywhere else: $155 a month on monthly billing, $145 a month on the 3-month term paid at once, $135 a month on the 6-month term paid at once and down to $125 a month on the 12-month term paid at once. A higher dose does not raise the price. The /pricing page carries the current figures.
No in person visit is required. The health assessment is completed online, a licensed provider with Wasef Health, PC reviews it, and in most states the treatment plan reaches you through online questionnaire and secure chat. There is no office to travel to in Delaware.
Prescribing decisions belong to licensed healthcare providers, who evaluate each patient on their own merits. Clinical services for applicable programs come from Wasef Health, PC, whose Medical Director is Michael Wasef, MD. Bodi Envi itself does not prescribe.
VialsRx is Bodi Envi's current pharmacy partner for GLP-1 prescriptions, including those written for Delaware patients. Pharmacy partners dispense and fulfill prescriptions when a licensed provider prescribes, and ship to your Delaware address. Pharmacy availability may vary by program and patient location.
It is not. Ozempic® and Wegovy® are FDA-approved products; personalized compounded semaglutide is a compounded medication, which the FDA does not review for safety, effectiveness or quality before it is marketed, and which is not equivalent to those products. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Yes. Bodi Envi is a LegitScript-certified telehealth platform. You can confirm the certification on LegitScript's own site through the badge in the footer of every page.
It does. Eligible adults in Delaware can be considered for personalized compounded tirzepatide as well as personalized compounded semaglutide, and a licensed provider with Wasef Health, PC advises which, if either, suits your health history. Micro-dose versions of both are also offered.
Yes. Micro-dose semaglutide is one of Bodi Envi's programs, and Delaware patients are assessed for it the same way as for the standard program. Whether it is prescribed is the decision of a licensed provider with Wasef Health, PC.
The next step belongs to the licensed provider with Wasef Health, PC, who reads your assessment and determines whether treatment is appropriate. Treatment is not guaranteed. If a patient is not qualified, a refund will be issued. If personalized compounded semaglutide is prescribed, the pharmacy partner fills the prescription and ships it to your Delaware address, and ongoing monitoring happens through the care team.
Important information about compounded medications
Personalized compounded semaglutide and personalized compounded tirzepatide are not FDA-approved and are not equivalent to FDA-approved products.
The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Treatment is not guaranteed. A licensed healthcare provider determines whether treatment is appropriate for each individual patient. Individual experiences and outcomes vary. If a patient is not qualified, a refund will be issued.
Bodi Envi is not a medical practice, pharmacy, or medication manufacturer. Brand names are trademarks of their respective owners.
Ready when you are
Start your personalized compounded semaglutide assessment in Delaware
Complete the online assessment in a few minutes. A licensed provider reviews it, and if personalized compounded semaglutide is right for you, your plan ships to your Delaware address. Treatment is not guaranteed, and the price you see is the price Delaware residents pay. If a patient is not qualified, a refund will be issued.